Country/Language
The investigational study medication, known as felzartamab, is a monoclonal antibody, which is an antibody that is made in a laboratory. This antibody is designed to block the activity of cells that attack the kidneys in lupus nephritis. This may help improve your symptoms and prevent the condition from getting worse.
Yes, every participant will receive the investigational study medication with no chance of receiving a placebo.
Investigational means the study medication is not approved by regulatory authorities like the US Food and Drug Administration (FDA), and it can only be used in clinical research studies like the HIB-202-101 study.